James Woys - 01 Mar 2026 Form 4 Insider Report for MOLINA HEALTHCARE, INC. (MOH)

Role: Chief Operating Officer
Signature: Jeff D. Barlow, by power of attorney for James Woys
Issuer symbol: MOH
Transactions as of: 01 Mar 2026
Net transactions value: +$2,277,814
Form type: 4
Filing time: 02 Mar 2026, 20:05:54 UTC
Previous filing: 06 Aug 2025
SEC: View on sec.gov

Quoteable Key Fact

"James Woys filed Form 4 for MOLINA HEALTHCARE, INC. (MOH) on 02 Mar 2026."

Quick Takeaways

This page summarizes James Woys's Form 4 filing for MOLINA HEALTHCARE, INC. (MOH).
2 reported transactions and 0 derivative rows are listed below.
Filing timestamp: 02 Mar 2026, 20:05.

What Changed

Previous filing in this sequence was filed on 06 Aug 2025.
Current net transaction value: +$2,277,814.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
WOYS JAMES	Chief Operating Officer	2180 HARVARD STREET, SUITE 400, SACRAMENTO	Jeff D. Barlow, by power of attorney for James Woys	02 Mar 2026	0001213947

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MOH	Common Stock	Tax liability	$202,268	-1,313	-1.8%	$154.05	73,018	01 Mar 2026	Direct	F1, F2
transaction	MOH	Common Stock	Award	$2,480,082	+17,016	+23%	$145.75	90,034	01 Mar 2026	Direct	F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,337 shares on March 1, 2026.
F2	Represents the closing price of the Issuer's common stock on February 27, 2026.
F3	Grant of restricted stock under the Issuer's 2025 Equity Incentive Plan.
F4	Represents the volume-weighted average price (VWAP) of the Company's common stock for the ten (10) trading dates immediately preceding the March 1, 2026 grant date.
F5	The shares shall vest as follows: The 17,016 newly granted shares shall vest in one-third increments on each of March 1, 2027, March 1, 2028, and March 1, 2029. Additional shares shall vest as follows: 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are vested.